The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy
Authors
Keywords
Indoleamine 2-3-dioxygenase (IDO), Immune tolerance, Cancer, Melanoma, IDO inhibition, Epacadostat, Indoximod
Journal
EUROPEAN JOURNAL OF CANCER
Volume 76, Issue -, Pages 167-182
Publisher
Elsevier BV
Online
2017-03-18
DOI
10.1016/j.ejca.2017.01.011

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.